Treatment of metastatic disease

Details for Australian Patent Application No. 2008264177 (hide)

Owner Glaxo Group Limited The University Of North Carolina At Chapel Hill Purdue Research Foundation

Inventors Kinch, Michael Scott; Kilpatrick, Katherine E.; Zantek, Nicole D.; Hein, Patrick W.

Agent Wynnes Patent & Trade Mark Attorneys

Pub. Number AU-A-2008264177

Parent 2006202023

Filing date 24 December 2008

Wipo publication date 5 February 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/18 (2006.01) - Sulfonamides

A61P 35/04 (2006.01) Antineoplastic agents

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

22 January 2009 Complete Application Filed

5 February 2009 Application Open to Public Inspection

  Published as AU-A-2008264177

19 May 2011 Assignment before Grant

  Purdue Research Foundation; Glaxo Group Limited; The University Of North Carolina At Chapel Hill The application has been assigned to Purdue Research Foundation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008264178-Method and apparatus for reducing interchannel interference in a wireless communication system

2008264176-Method for operating a wind energy plant